VMD vs. AHCO, PNTG, AVAH, CSTL, TALK, AUNA, DCGO, FLGT, SBC, and CELC
Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include AdaptHealth (AHCO), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Talkspace (TALK), Auna (AUNA), DocGo (DCGO), Fulgent Genetics (FLGT), SBC Medical Group (SBC), and Celcuity (CELC). These companies are all part of the "healthcare" industry.
Viemed Healthcare vs.
AdaptHealth (NASDAQ:AHCO) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk.
In the previous week, Viemed Healthcare had 2 more articles in the media than AdaptHealth. MarketBeat recorded 3 mentions for Viemed Healthcare and 1 mentions for AdaptHealth. Viemed Healthcare's average media sentiment score of 1.24 beat AdaptHealth's score of 0.43 indicating that Viemed Healthcare is being referred to more favorably in the news media.
AdaptHealth has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500.
AdaptHealth presently has a consensus price target of $12.20, suggesting a potential upside of 43.82%. Given AdaptHealth's higher probable upside, equities research analysts clearly believe AdaptHealth is more favorable than Viemed Healthcare.
AdaptHealth received 81 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 61.31% of users gave AdaptHealth an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.
Viemed Healthcare has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 4.4% of AdaptHealth shares are owned by insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Viemed Healthcare has a net margin of 4.87% compared to AdaptHealth's net margin of -6.57%. AdaptHealth's return on equity of 9.62% beat Viemed Healthcare's return on equity.
Summary
Viemed Healthcare beats AdaptHealth on 12 of the 19 factors compared between the two stocks.
Get Viemed Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viemed Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:VMD) was last updated on 2/22/2025 by MarketBeat.com Staff
Free VMD Stock Alerts